Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drug adjuncts for treating alcohol dependence.

Gregory B Collins1, Mark S McAllister, Kamala Adury

  • 1Section head, Alcohol and Drug Recovery Center, Department of Psychiatry and Psychology, Cleveland Clinic, Cleveland Clinic Foundation, OH 44195, USA. colling@ccf.org

Cleveland Clinic Journal of Medicine
|July 19, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reprint of "Characterisation and modelling of the thermorheological properties of pharmaceutical polymers and their blends using capillary rheometry: Implications for hot melt processing of dosage forms".

International journal of pharmaceutics·2015
Same author

E-cigarettes: Safe to recommend to patients?

Cleveland Clinic journal of medicine·2015
Same author

Characterisation and modelling of the thermorheological properties of pharmaceutical polymers and their blends using capillary rheometry: Implications for hot melt processing of dosage forms.

International journal of pharmaceutics·2015
Same author

Correction: Quitting smoking: still a challenge, but newer tools show promise.

Cleveland Clinic journal of medicine·2015
Same author

Quitting smoking: still a challenge, but newer tools show promise.

Cleveland Clinic journal of medicine·2015
Same author

Medication-assisted treatment of opiate dependence is gaining favor.

Cleveland Clinic journal of medicine·2013
Same journal

A 20-year-old woman with a 9-year history of shortness of breath.

Cleveland Clinic journal of medicine·2026
Same journal

A 70-year-old man with lower-extremity weakness and falls.

Cleveland Clinic journal of medicine·2026
Same journal

Treatment-refractory hypothyroidism: Don't just increase the dose.

Cleveland Clinic journal of medicine·2026
Same journal

In Reply: Beyond histologic improvement in MASH.

Cleveland Clinic journal of medicine·2026
Same journal

Comfort care: Creating a plan for hospitalized patients and their families.

Cleveland Clinic journal of medicine·2026
Same journal

Localized dead bone, a potential hint to an underlying condition.

Cleveland Clinic journal of medicine·2026
See all related articles

Current treatments for alcoholism include FDA-approved drugs like disulfiram, naltrexone, and acamprosate. Research is exploring other medications to aid alcohol dependence recovery and reduce related health issues.

Area of Science:

  • Pharmacology
  • Addiction Medicine
  • Neuroscience

Background:

  • Alcoholism, or alcohol dependence, is a complex condition with significant public health implications.
  • Existing pharmacotherapies aim to support abstinence and reduce alcohol consumption.
  • Understanding the pathophysiology of alcoholism is crucial for developing new treatments.

Purpose of the Study:

  • To review currently approved and experimental drugs for alcoholism treatment.
  • To highlight the potential of novel pharmacologic interventions for alcohol dependence.

Main Methods:

  • Review of FDA-approved medications for alcoholism.
  • Discussion of off-label and experimental drug use in alcohol dependence.
  • Exploration of the pathophysiologic basis of alcoholism.

Related Experiment Videos

Main Results:

  • Disulfiram, naltrexone, and acamprosate are FDA-approved for alcoholism.
  • Nalmefene, topiramate, and ondansetron are used experimentally or off-label.
  • Ongoing research into the biological underpinnings of alcoholism.

Conclusions:

  • A range of pharmacologic options exist for treating alcohol dependence.
  • Further research into the pathophysiology of alcoholism may lead to novel drug development.
  • Novel medications hold promise for improving abstinence rates and reducing alcohol-related harm.